Rodos BioTarget GmbH:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Rodos BioTarget GmbH - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10828
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ドイツ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Rodos BioTarget GmbH (RBT) is a biopharmaceutical company that develops drug delivery platforms. The company provides products such as targosphere, targobiotics and targovir. Its targosphere finds application in treating various infectious diseases such as virus caused HCV and hepatitis c and HIV and AIDS; and bacteria caused tuberculosis, legionellosis, methicillin-resistant staphylococcus aureus, and others. RBT’s technology platform targosphere enables the targeted delivery of active agents and vaccines into antigen-presenting cells. The company’s targovir also develops CLR-TS for targeted delivery of antivirals to eradicate intracellular viral reservoirs in the form of infectious virions and proviral DNA integrated into the host cell’s genome. It has partnership with university and institute. RBT is headquartered in Hannover, Germany.

Rodos BioTarget GmbH – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Rodos BioTarget GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Rodos BioTarget GmbH, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Rodos BioTarget GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Rodos BioTarget GmbH, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Rodos BioTarget GmbH, Medical Devices Deals, 2012 to YTD 2018 9
Rodos BioTarget GmbH, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Rodos BioTarget GmbH, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Rodos BioTarget Raises US$3.4 Million In Growth Financing 11
Partnerships 12
Rodos Biotarget and Pharis Biotec Enter into Co-Development Agreement 12
Rodos BioTarget Enters into Agreement with Biozeus 13
Rodos BioTarget GmbH – Key Competitors 14
Rodos BioTarget GmbH – Key Employees 15
Rodos BioTarget GmbH – Locations And Subsidiaries 16
Head Office 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
Rodos BioTarget GmbH, Pharmaceuticals & Healthcare, Key Facts 2
Rodos BioTarget GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Rodos BioTarget GmbH, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Rodos BioTarget GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Rodos BioTarget GmbH, Deals By Therapy Area, 2012 to YTD 2018 8
Rodos BioTarget GmbH, Medical Devices Deals, 2012 to YTD 2018 9
Rodos BioTarget GmbH, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Rodos BioTarget Raises US$3.4 Million In Growth Financing 11
Rodos Biotarget and Pharis Biotec Enter into Co-Development Agreement 12
Rodos BioTarget Enters into Agreement with Biozeus 13
Rodos BioTarget GmbH, Key Competitors 14
Rodos BioTarget GmbH, Key Employees 15

List of Figures
Rodos BioTarget GmbH, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Rodos BioTarget GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Rodos BioTarget GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Rodos BioTarget GmbH, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Rodos BioTarget GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Rodos BioTarget GmbH, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Rodos BioTarget GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Rodos BioTarget GmbH, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Rodos BioTarget GmbH, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Rodos BioTarget GmbH:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Penn Virginia Corp (PVAC):石油・ガス:M&Aディール及び事業提携情報
    Summary Penn Virginia Corp (Penn Virginia) is an independent oil and gas company. It explores, develops, and produces crude oil, Natural gas liquids (NGL), and natural gas. The company’s operations consist primarily of drilling unconventional horizontal development wells and operating producing well …
  • Intrasense SA (ALINS):企業の財務・戦略的SWOT分析
    Summary Intrasense SA (Intrasense) is a healthcare technology company that offers software solution for analysis and visualisation of medical images. The company offers a range of clinical apps such as lesion tracking solution, analysis tools, virtual colonoscopy, and lung nodule follow-up software, …
  • Even Construtora E Incorporadora Sa:企業の戦略・SWOT・財務分析
    Even Construtora E Incorporadora Sa - Strategy, SWOT and Corporate Finance Report Summary Even Construtora E Incorporadora Sa - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • Hainan Shuangcheng Pharmaceuticals Co Ltd (002693):製薬・医療:M&Aディール及び事業提携情報
    Summary Hainan Shuangcheng Pharmaceuticals Co Ltd (Shuangcheng Pharma) is a pharmaceutical company that develops, manufactures and markets generic peptide drugs, finished dosages and active pharmaceutical ingredients. Its products include thymalfasin, thymopetin, somatostatin, levocarnitine, famotid …
  • Ocular Therapeutix Inc (OCUL):企業の財務・戦略的SWOT分析
    Summary Ocular Therapeutix Inc (Ocular Therapeutix), formerly I-Therapeutix Inc, is a biopharmaceutical company that discovers, develops and commercializes therapies for treating eye diseases. The company’s lead product candidate DEXTENZA is used for the treatment of post-surgical ocular inflammatio …
  • Bank Alfalah Ltd:企業の戦略・SWOT・財務分析
    Bank Alfalah Ltd - Strategy, SWOT and Corporate Finance Report Summary Bank Alfalah Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Innergex Renewable Energy Inc (INE):電力:M&Aディール及び事業提携情報
    Summary Innergex Renewable Energy Inc (Innergex) is an independent renewable power producer. It develops, acquires, owns and operates hydroelectric facilities, wind farms, and solar photovoltaic geothermal power facilities. Through long-term power purchase agreements, the company sells electricity t …
  • CTBC Financial Holding Co Ltd (2891):企業の財務・戦略的SWOT分析
    CTBC Financial Holding Co Ltd (2891) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • TH Heavy Engineering Bhd (THHEAVY):企業の財務・戦略的SWOT分析
    TH Heavy Engineering Bhd (THHEAVY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Pilatus Group:企業の戦略・SWOT・財務情報
    Pilatus Group - Strategy, SWOT and Corporate Finance Report Summary Pilatus Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • The Ensign Group Inc (ENSG):企業の財務・戦略的SWOT分析
    The Ensign Group Inc (ENSG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Leukemia & Lymphoma Society Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary The Leukemia & Lymphoma Society Inc (LLS) is a voluntary health organization that focuses on funding research for identifying cure for blood cancer. The organization also assures access to treatments for blood cancer patients. Its offers patient support, health education, policy advocacy, an …
  • bioMerieux SA.:企業の戦略・SWOT・財務分析
    bioMerieux SA. - Strategy, SWOT and Corporate Finance Report Summary bioMerieux SA. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • PT. Matahari Putra Prima Tbk (MPPA):企業の財務・戦略的SWOT分析
    PT. Matahari Putra Prima Tbk (MPPA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Bank Of Cyprus Public Company Ltd:企業の戦略・SWOT・財務分析
    Bank Of Cyprus Public Company Ltd - Strategy, SWOT and Corporate Finance Report Summary Bank Of Cyprus Public Company Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • The Bank Of East Asia, Limited:企業の戦略・SWOT・財務分析
    The Bank Of East Asia, Limited - Strategy, SWOT and Corporate Finance Report Summary The Bank Of East Asia, Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Toro Energy Ltd (TOE):企業の財務・戦略的SWOT分析
    Toro Energy Ltd (TOE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Daimler AG (DAI):企業の財務・戦略的SWOT分析
    Daimler AG (DAI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • InterOil Exploration & Production ASA Oil & Gas Exploration and Production Operations and Cost Analysis – Q3, 2017
    InterOil Exploration & Production ASA Oil & Gas Exploration and Production Operations and Cost Analysis - Q3, 2017 Summary InterOil Exploration & Production ASA (InterOil Exploration & Production) is an oil and gas company that provides petroleum exploration services. The company acquires, explores, …
  • Five Star Senior Living Inc (FVE):企業の財務・戦略的SWOT分析
    Summary Five Star Senior Living Inc (Five Star), formerly Five Star Quality Care Inc is a healthcare service provider that offers senior living and patient care services. The center’s services include independent living, assisted living, skilled nursing care, memory care, dining and nutrition, hospi …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆